Two new lawsuits have been filed against Baylor St. Luke’s Medical Center, the fourth and fifth malpractice complaints involving heart transplants at the Houston hospital since the Houston Chronicle and ProPublica exposed problems with its transplant program last year.

Research published in the Journal of the American Heart Association Jan. 13 has concluded administering PCSK9 inhibitors to acute MI patients ahead of ischemia can mitigate the potential negative neurological effects that come with treatment.

A new Medscape survey found 44 percent of U.S. physicians—including 43 percent of cardiologists—feel burned out.

Hong Kong researchers have identified “a previously unknown burden” of mental illness among those with young-onset type 2 diabetes (YOD), with a study suggesting more than one-third of days those patients spend in the hospital before age 40 can be attributed to mental health.

Measuring blood levels of vaspin could independently predict major adverse cardiac events (MACE) in patients who have suffered acute myocardial infarction (AMI), according to research published Jan. 16 in the Journal of the American Heart Association, potentially improving early risk stratification in heart attack survivors.

Abbott plans to acquire Cephea Valve Technologies, a company developing a transcatheter mitral valve replacement (TMVR) device, the Chicago-area healthcare giant announced Jan. 16.

Following simple heart health guidelines may also cut individuals’ 10-year risk of developing diabetes, Ohio State researchers reported Jan. 16.

Copayment vouchers for P2Y12 inhibitors modestly improved the likelihood that patients would continue taking the guideline-recommended medications for one year after myocardial infarction, according to a study published in JAMA. However, patients supplied with this financial assistance didn’t see a subsequent improvement in clinical outcomes.

ST-segment elevation myocardial infarction (STEMI) survivors covered by Medicaid have lower rates of revascularization and higher rates of in-hospital mortality than their counterparts with private insurance, according to a study published in Circulation: Cardiovascular Quality and Outcomes.

In the past year bone broth—the result of simmering animal bones with herbs and vegetables for anywhere between 20 minutes and 20 hours—has been lauded as a superfood, promoted as a Hollywood diet and linked to benefits like better gut health and stronger joints. Now, research out of Spain is proving at least some of those claims are true.